Prescribed CBD could help people quit cannabis

A benchmark clinical trial published today shows that cannabidiol (CBD) could be a safe and effective treatment for problematic cannabis use.  Results from the first-ever randomised clinical trial of CBD for cannabis use disorder suggests that prescribed doses of the non-intoxicating constituent part of the cannabis plant could help people kick the habit. In the  …


Launch of the Medical Psychedelics Working Group

On Tuesday July 14th, 2020, Drug Science will launch a new working group of experts, policy makers and scientists. Its primary role is to campaign for the rescheduling of all psychedelic drugs for research and medical purposes. However, current UK regulations have created serious and considerable barriers to legitimate research associated with Schedule 1 regulations.  …

Medical Cannabis: What Lessons Can Be Learned for the UK?

Article from Drug Science’s Head of Research – Dr Anne Schlag An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access to this medicine, with fewer than 10 NHS prescriptions having been written  …


Project Twenty21

Drug Science launched Europe’s first and biggest national medical cannabis registry, called Project Twenty21, on the 7th November 2019. Project TWENTY21 aims to enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical  …


Response to the Nature article: Moving from prison to PhD

There are fewer than ten empirical studies on the transition from prison to university so the article “Moving from Prison to PhD” is a step in the right direction to highlight this neglected and important topic. Globally, millions of individuals are arrested and charged with drug offences every year. Most of them will be scarred  …


Statement on the dangers posed by e-cigarettes

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …


New Zealand revises sentencing framework for methamphetamine offences

Dr James Foulds, Consultant forensic psychiatrist, Christchurch New Zealand Methamphetamine smoking is the commonest form of stimulant use in New Zealand. Asian importation has increased recently, and the drug has got much cheaper. However, despite harsh sanctions, dealing remains attractive for many people- including those who sell the drug to fund their own use. Until  …


New analysis of alcohol and cannabis – what’s the harm?

This blog discusss DrugScience's latest multi-criterion decision analysis of cannabis and alcohol regulation. Read the open access paper here. We’re all used to weighing up the benefits and pitfalls in our decision making. Is it worth the cost? Is it safe? Will I be able to get up in the morning? These are all simple  …

A multi-criterion decision analysis applied to alcohol and cannabis regulation

In collaboration with drug experts in Norway and the UK, multi-criteria decision analysis has been applied to evaluating drug policies for the first time - read the paper here. We have previously applied this technique to investigate harms of common recreational drugs in 2010, and nicotine-containing products in 2014. Drug policy, whether for legal or  …

Ketamine treatment for depression

A review and analysis of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression. The review concludes that further restrictions around ketamine are not neccesary and provides a set of recomendations for oversight bodies that would support safe, effective, and ethical use. Read it here Related Content Medical cannabis in the UK: From  …

Ketamine as an essential medicine

A letter to The Lancet endorsing the WHO Expert Committee on Drug Dependence's conclusion that concerns over recreational ketamine abuse in no way outweigh ketamine's role as a life-saving anasthetic and essential medicine. Read it here Related Content The UK needs common sense about ketamineFebruary 10 2015 DrugScience ketamine reviewApril 3 2011

Khat and alcohol harm comparison

As the khat ban approached, DrugScience commissioned a review of khat harms, following the detailed and rigorous report from the UK Government Advisory Council on the Misuse of Drugs earlier that year. DrugScience's review provided independent corroboration of the ACMD’s findings that the harms of khat cannot justify a ban and that community measures should  …